1 / 5

Dry Powder Inhaler Device Market

Dry Powder Inhaler Device Market<br>

swati15
Download Presentation

Dry Powder Inhaler Device Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dry Powder Inhaler Dry Powder Inhaler Device Market to Reach Device Market to Reach USD 912.3 Million By USD 912.3 Million By 2026 2026 www.reportsanddata.com www.reportsanddata.com

  2. Market Market Summary Summary The global Dry Powder Inhaler Device Market is estimated to reach USD 912.3 Million by 2026, according to a new report by Reports and Data. This can be mainly associated due to increasing incidences of hereditary diseases, lung disorders and increasing pollution due to the high discharge of harmful chemicals are significant reasons for chronic respiratory diseases that are generating a significant demand for the dry powder inhalers. Improvised efficiency of dry powder inhalers and better results in comparison with alternative therapies is a driving factor that will aid market growth. Based on statistics, the rise in elderly population base inclined to respiratory infections will boost market growth. A significant cause of lung disorders in teenagers and adults is the addiction to nicotine. Increases in variations of hormones due to the changing lifestyle which can trigger the need for having an addiction are also significant factors stimulating Market demand. Dry powder inhaler market in North America accounts for the largest share of 22.30% in 2018, which is driven due to the presence of world-class healthcare infrastructure with technologically advanced practice, a high number of people with respiratory problems, higher spending, strict guidelines and presence of leading industry players in the region. The U.S. will boost the North America dry powder inhaler industry due to the increasing predominance of asthma and other respiratory diseases copulated with the growing geriatric population. Read More: https://www.reportsanddata.com/report-detail/dry-powder-inhaler-device-market

  3. Market Market Summary Summary Further key findings from the report suggest • The asthma segment is valued at USD 205.1 million in 2018 and is estimated to reach USD 299.2 million by 2026 at a CAGR of 4.7% during the forecast period, due to an increase in air pollution levels across the world and increase in the incidence of asthma particularly in developed countries. • Single-use devices are observing improved demand as they have the potential to overcome the challenges and offer a hygienic & clean device. This segment is valued at USD 393.5 million in 2018 and is estimated to reach USD 563.8 million by 2026 at a CAGR of 4.5% during the forecast period. A significant trend in the market is the demand for accessibility and easy handling of respiratory devices. • Multiple dry powder inhalers are popular among patients with respiratory diseases as an additional device for different places such as cars, homes and job sites. With single-use dry powder inhalers, patients are allowed to carry the exact dose of inhalations needed in blister packs, which in turn promotes handling and comfort. Key participants include 3M Company, Astrazeneca Plc., Chiesi Farmaceutici S.p.A., GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, BoehringerIngelheim GmbH, MannKind Corporation, and Vectura Group Plc. •

  4. Market Market Summary Summary For the purpose of this report, Reports and Data have segmented global Dry Powder Inhaler Device Market on the basis of Type, Product, Application, End Users and region: • End User Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026) Hospitals and pharmacies Retail pharmacies Drug stores • • • • Application Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026) Asthma COPD Diabetes Hereditary diseases Other • • • • • • Type Outlook (Volume, Thousand Units; and Revenue, USD Million; 2016-2026) Single dose Multi-dose • • •

  5. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Direct Line: +1 +1- -212 212- -710 710- -1370 1370 E-mail: sales@reportsanddata.com John John Watson Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com

More Related